Palatin Technologies Inc. (PTN) gains 2.20% for July 21

Equities Staff  |

Palatin Technologies Inc. (NYSE: PTN) shares gained 2.20%, or $0.0115 per share, to close Wednesday at $0.54. After opening the day at $0.52, shares of Palatin fluctuated between $0.55 and $0.52. 600,246 shares traded hands a decrease from their 30 day average of 1,991,926. Wednesday's activity brought Palatin’s market cap to $123,122,595.

Palatin is headquartered in Cranbury, New Jersey..

About Palatin Technologies Inc.

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.

Visit Palatin Technologies Inc.’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Palatin Technologies Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: Palatin Technologies Inc.’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content